Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor
PHASE1
This study is a open-label, phase I, dose escalation clinical study to eval...
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Solid Tumor or Lymphoma
PHASE1
This study is a first-in-class open-label phase I human clinical study to e...
A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients
PHASE2
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of HLX26...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University